COMMUNIQUÉS West-GlobeNewswire

-
Herantis Pharma Oyj: Manager’s Transactions - Inveni Life Sciences Fund I Ky
31/05/2019 -
ASLAN Pharmaceuticals Acquires Full Global Commercial Rights for ASLAN004 From CSL
31/05/2019 -
Oncology Venture publishes Q1 report for 2019
31/05/2019 -
Kiadis Pharma raises c.EUR 28 million in a private placement of c.3.7 million new shares
31/05/2019 -
Herantis Pharma Plc’s nomination of Vice Chairman
31/05/2019 -
Innate Pharma announces publication in Cell on innovative multifunctional NKp46 NK cell engagers (NKCEs)
31/05/2019 -
Innate Pharma annonce une publication dans Cell sur des anticorps multispecifiques innovants engageant les cellules NK via NKp46
31/05/2019 -
BrainStorm Presents Poster at Consortium of Multiple Sclerosis Centers (CMSC) 33rd Annual Meeting
31/05/2019 -
Bone Therapeutics to participate in upcoming conferences
31/05/2019 -
Bone Therapeutics annonce sa participation à plusieurs évènements sectoriels
31/05/2019 -
Roche and GE Healthcare launch NAVIFY Tumor Board with medical imaging capabilities to enable more personalised treatment decisions in cancer care
31/05/2019 -
Myovant Sciences Announces Pricing of $125 Million Public Offering of Common Shares
31/05/2019 -
Amicus Therapeutics Prices Underwritten Offering of Common Stock
31/05/2019 -
Ascent Industries Provides Bi-Weekly Default Status Report
31/05/2019 -
Mesoblast Reports Financial Results and Operational Highlights for the Period Ended March 31, 2019
31/05/2019 -
BeiGene Announces Acceptance of a Supplemental New Drug Application in China for Tislelizumab in Urothelial Carcinoma
31/05/2019 -
BeiGene Announces Acceptance of Supplemental Import Drug Application in China for ABRAXANE® in Metastatic Pancreatic Cancer
31/05/2019 -
Extendicare Announces Voting Results from the 2019 Annual and Special Meeting of Shareholders and Board Changes
31/05/2019 -
Revive Therapeutics Announces Results for the Three and Nine Months Ended March 31, 2019
31/05/2019
Pages